Natixis Advisors LLC cut its holdings in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN - Free Report) by 9.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 53,961 shares of the company's stock after selling 5,688 shares during the quarter. Natixis Advisors LLC's holdings in Ryan Specialty were worth $3,986,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of RYAN. Bessemer Group Inc. raised its stake in shares of Ryan Specialty by 2.5% in the fourth quarter. Bessemer Group Inc. now owns 3,283,216 shares of the company's stock valued at $210,651,000 after purchasing an additional 79,976 shares in the last quarter. Principal Financial Group Inc. increased its position in shares of Ryan Specialty by 66.4% during the 1st quarter. Principal Financial Group Inc. now owns 3,051,356 shares of the company's stock worth $225,404,000 after purchasing an additional 1,218,147 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Ryan Specialty by 2.7% during the 4th quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company's stock worth $115,468,000 after acquiring an additional 46,960 shares during the last quarter. Barclays PLC increased its holdings in shares of Ryan Specialty by 3.0% during the 4th quarter. Barclays PLC now owns 1,690,279 shares of the company's stock worth $108,449,000 after acquiring an additional 48,536 shares during the last quarter. Finally, Stephens Investment Management Group LLC lifted its position in shares of Ryan Specialty by 2.2% during the 1st quarter. Stephens Investment Management Group LLC now owns 1,642,527 shares of the company's stock worth $121,333,000 after buying an additional 34,932 shares during the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on RYAN shares. UBS Group decreased their price target on Ryan Specialty from $84.00 to $80.00 and set a "buy" rating for the company in a research note on Monday, August 4th. Wells Fargo & Company cut their price target on Ryan Specialty from $63.00 to $60.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. The Goldman Sachs Group upgraded Ryan Specialty from a "neutral" rating to a "buy" rating and increased their price target for the stock from $74.00 to $81.00 in a report on Tuesday, May 13th. Morgan Stanley dropped their price target on Ryan Specialty from $80.00 to $78.00 and set an "overweight" rating on the stock in a report on Monday, July 14th. Finally, Barclays reduced their target price on Ryan Specialty from $83.00 to $79.00 and set an "overweight" rating for the company in a research report on Monday, July 7th. Three investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. According to data from MarketBeat, Ryan Specialty currently has a consensus rating of "Moderate Buy" and an average target price of $77.30.
Read Our Latest Stock Analysis on Ryan Specialty
Ryan Specialty Price Performance
RYAN stock traded down $1.02 during mid-day trading on Friday, reaching $58.53. The company's stock had a trading volume of 1,344,980 shares, compared to its average volume of 1,485,492. The stock has a market cap of $15.36 billion, a PE ratio of 167.23, a P/E/G ratio of 1.69 and a beta of 0.64. The company has a current ratio of 1.01, a quick ratio of 1.05 and a debt-to-equity ratio of 2.88. Ryan Specialty Holdings Inc. has a fifty-two week low of $55.77 and a fifty-two week high of $77.16. The company's 50 day moving average is $65.30 and its two-hundred day moving average is $67.92.
Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $0.66 EPS for the quarter, meeting analysts' consensus estimates of $0.66. Ryan Specialty had a net margin of 6.81% and a return on equity of 48.70%. The company had revenue of $855.17 million for the quarter, compared to analyst estimates of $837.52 million. During the same period in the previous year, the business posted $0.58 earnings per share. Ryan Specialty's quarterly revenue was up 23.0% on a year-over-year basis. Equities research analysts expect that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current year.
Ryan Specialty Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 26th. Shareholders of record on Tuesday, August 12th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, August 12th. Ryan Specialty's dividend payout ratio is 137.14%.
Insiders Place Their Bets
In other news, EVP Mark Stephen Katz sold 14,377 shares of the firm's stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $65.84, for a total value of $946,581.68. Following the transaction, the executive vice president directly owned 1,117 shares in the company, valued at approximately $73,543.28. This trade represents a 92.79% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director David P. Bolger sold 5,000 shares of Ryan Specialty stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $70.80, for a total transaction of $354,000.00. Following the completion of the transaction, the director directly owned 71,467 shares in the company, valued at $5,059,863.60. This represents a 6.54% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 52.21% of the company's stock.
Ryan Specialty Company Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report